RIRBX
Price
$72.48
Change
-$0.25 (-0.34%)
Updated
Feb 21 closing price
Net Assets
110.16B
SLFYX
Price
$7.99
Change
-$0.00 (-0.00%)
Updated
Feb 21 closing price
Net Assets
557.65M
Ad is loading...

RIRBX vs SLFYX

Header iconRIRBX vs SLFYX Comparison
Open Charts RIRBX vs SLFYXBanner chart's image
American Funds Capital Income Bldr R2
Price$72.48
Change-$0.25 (-0.34%)
VolumeN/A
Net Assets110.16B
SEI Multi-Asset Inflation Mgd Y (SIMT)
Price$7.99
Change-$0.00 (-0.00%)
VolumeN/A
Net Assets557.65M
RIRBX vs SLFYX Comparison Chart
Loading...
View a ticker or compare two or three
VS
RIRBX vs. SLFYX commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RIRBX is a StrongBuy and SLFYX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
RIRBX has more cash in the bank: 110B vs. SLFYX (558M). SLFYX pays higher dividends than RIRBX: SLFYX (4.00) vs RIRBX (2.55). RIRBX was incepted earlier than SLFYX: RIRBX (23 years) vs SLFYX (10 years). RIRBX is a more actively managed with annual turnover of: 106.00 vs. SLFYX (93.00). RIRBX has a lower initial minimum investment than SLFYX: RIRBX (250) vs SLFYX (100000). RIRBX annual gain was more profitable for investors over the last year : 11.30 vs. SLFYX (8.16). SLFYX return over 5 years is better than : 29.43 vs. RIRBX (24.48).
RIRBXSLFYXRIRBX / SLFYX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence23 years10 years-
Gain YTD4.9834.172119%
Front LoadN/AN/A-
Min. Initial Investment2501000000%
Min. Initial Investment IRAN/AN/A-
Net Assets110B558M19,713%
Annual Yield % from dividends2.554.0064%
Returns for 1 year11.308.16138%
Returns for 3 years11.9311.93100%
Returns for 5 years24.4829.4383%
Returns for 10 years31.5425.28125%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KELYA13.870.18
+1.31%
Kelly Services
LRMR3.19-0.08
-2.45%
Larimar Therapeutics
EXPE196.81-8.33
-4.06%
Expedia Group
OSIS202.27-12.10
-5.64%
OSI Systems
SABS1.82-0.13
-6.67%
SAB Biotherapeutics